Equities

Shanghai OPM Biosciences Co Ltd

688293:SHH

Shanghai OPM Biosciences Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)25.86
  • Today's Change0.86 / 3.44%
  • Shares traded360.77k
  • 1 Year change-46.08%
  • Beta--
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,4841,717343
Total Receivables, Net1189551
Total Inventory494434
Prepaid expenses8.22133.25
Other current assets, total----9.53
Total current assets1,6591,869441
Property, plant & equipment, net297264143
Goodwill, net------
Intangibles, net394042
Long term investments24014468
Note receivable - long term------
Other long term assets------
Total assets2,3022,348747
LIABILITIES
Accounts payable372113
Accrued expenses182016
Notes payable/short-term debt0.262040
Current portion long-term debt/capital leases8.60117.37
Other current liabilities, total6.111719
Total current liabilities718996
Total long term debt616174
Total debt7092122
Deferred income tax0.590.26--
Minority interest(0.78)----
Other liabilities, total121315
Total liabilities143163185
SHAREHOLDERS EQUITY
Common stock1158261
Additional paid-in capital1,8991,925428
Retained earnings (accumulated deficit)15917873
Treasury stock - common(14)----
Unrealized gain (loss)------
Other equity, total0.190.12--
Total equity2,1592,185562
Total liabilities & shareholders' equity2,3022,348747
Total common shares outstanding115115115
Treasury shares - common primary issue0.2400
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.